Check the Package: Lipofit Extreme 2.0 Sold Online Nationwide Is Recalled

DRUG RECALL — HEALTHCARE, MENTAL HEALTH & AGING

Check the package: Lipofit Extreme 2.0 sold online nationwide is recalled.

This is an exact-lot warning—not a claim about every weight-loss supplement. FDA testing found undeclared fluoxetine in the daytime tablets and toxic DNP in the nighttime tablets. If the product, lot and expiration all match, the recall says to stop using it immediately.

The Rockland Edit drug-recall card identifying Lipofit Extreme 2.0 Fat Burner, lot 25M12F, expiration September 2027, with AM and PM tablet warnings and an instruction to stop using a matching package — Drug-recall identification card by The Rockland Edit, based on the FDA-posted company announcement. It is an original editorial graphic—not a product photograph, package label or individualized medical instruction.

Match every detail

Product: Lipofit Extreme Fat Burner 2.0.
Package: Daytime (AM) and nighttime (PM) tablets.
Lot: 25M12F.
Expiration: 09/2027.

If the lot and expiration match

Stop using the product immediately.
Keep it separated from children and other people. Do not sell, give or transfer it to anyone else.
Contact Ana Salazar Modela Tu Cuerpo Inc. at 954-305-1004 or yandrydy@gmail.com for return or disposition instructions.
Do not mail or dispose of the package until the company provides those instructions.

If you experienced a problem that may be related to taking the product, the recall says to contact a physician or healthcare provider. Patients and healthcare professionals may also report adverse reactions or product-quality problems through the FDA’s MedWatch program ↗.

What FDA testing found

The FDA-posted company announcement says laboratory analysis found undeclared fluoxetine in the AM tablets and undeclared 2,4-dinitrophenol, or DNP, in the PM tablets. Fluoxetine is an active ingredient in FDA-approved prescription drugs. DNP is a toxic substance that is not approved by FDA for any use and is illegally marketed for weight loss. The issue here is not prescribed fluoxetine taken under a clinician’s care; it is two undeclared substances in a product marketed as a dietary supplement.

Why the recall is serious

The company’s FDA-posted risk statement says the combination can cause serious or potentially life-threatening effects. It lists nausea, vomiting, sweating, dizziness and headaches, as well as dangerous heart rhythms, rapid heart rate, cardiac arrest, seizures, abnormal bleeding, suicidal thoughts, dangerously high body temperature and rapid breathing. It also says certain medication combinations can further increase the risk of fatal cardiac events.

The company reported no known adverse events related to the recall as of August 27. That does not establish that a reader’s symptoms were or were not caused by the product; individual medical questions belong with a healthcare professional.

What nationwide online sales confirm

The announcement says the product was sold online directly to individual consumers throughout the United States. That means a New York or Rockland resident could have purchased it without a local store carrying it. The public notice does not identify a Rockland buyer, order, illness, retailer or adverse event, and The Rockland Edit has not confirmed one.

The useful version is narrow: check Lipofit Extreme 2.0, lot 25M12F and expiration 09/2027. If every detail matches, stop using it, keep it away from other people and contact the company before mailing or disposing of it.

Primary source: FDA-posted Ana Salazar Modela Tu Cuerpo company announcement ↗, dated August 27 and published August 31, 2026. Product identifiers, online distribution, consumer instructions, contact information and adverse-event statement rechecked August 31, 2026, at 3:49 p.m. EDT. FDA posts company announcements as a public service and does not endorse the product or company. This service guide is not individualized medical advice.